Eiko LifeSciences has completed acquisition of 25.01% stake in the equity share capital of Reflux Pharmaceuticals (RPPL) at a consideration of Rs 7.008 crore. Pursuant to the said acquisition, RPPL has become an Associate Company of Eiko Lifesciences.
The said acquisition of stake in RPPL would benefit the Company in its long-term strategic growth plan to diversify its portfolio and set its footprints in various Geographic areas. The company will also be preferred source of supply for some of the key raw materials to RPPL and help them in sourcing key Active Pharma Ingredients (APIs) which help them in its manufacturing process, along with it both companies will co-develop and market new products to strengthen its global network.
Eiko LifeSciences is a leading manufacturer, supplier and exporter of Speciality Chemicals and Pharma Intermediates in India and Globally.
